Pacifica, CA, United States of America

Jeffrey Homer Clarke


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Jeffrey Homer Clarke:

Title: Unveiling the Innovative Mind of Jeffrey Homer Clarke from Pacifica, CA

Introduction:

Jeffrey Homer Clarke, a visionary inventor based in Pacifica, CA, has made significant contributions to the field of antithrombotic therapy with his groundbreaking inventions.

Latest Patents:

Clarke's latest patents include the Protease-resistant thrombomodulin analogs, which revolutionize the realm of single-chain thrombomodulin and its analogs. These advancements are crucial as they are not susceptible to cleavage by proteases, ensuring the retention of biological activity. The inventions encompass novel proteins, nucleic acid gene sequences, pharmaceuticals, and methods for inhibiting thrombotic activity.

Career Highlights:

With a total of 3 patents to his name, Clarke has emerged as a key player in the realm of biological and pharmaceutical innovation. His work at Schering Aktiengesellschaft has propelled the industry forward, showcasing his dedication to advancing healthcare solutions.

Collaborations:

In his journey of innovation, Clarke has collaborated with esteemed professionals such as David Richard Light and William H Andrews. Together, they have synergized their expertise to drive research and development in the field, setting new benchmarks for excellence.

Conclusion:

Jeffrey Homer Clarke's inventive spirit and commitment to scientific excellence continue to inspire awe in the world of antithrombotic therapy. His patents stand as a testament to his ingenuity and unwavering pursuit of advancements that make a tangible difference in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…